Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted oral protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using tunable mono-valent small molecules, allowing for the development of more drug-like, orally bioavailable and CNS-accessible protein degraders.
Dunad Therapeutics Address
125 Old Broad Street Cambridge, Cambridge
Dunad Therapeutics Email
Past Companies
Dunad TherapeuticsChief Scientific Officer
Entasis TherapeuticsChief Scientific Officer
AstraZenecaExecutive Director - Infection Chemistry